David John Blackbourn PhD FRSB is currently Professor of Virology and Director of the Institute of Medical Sciences at the University of Aberdeen. His research interests emphasise virus understanding how viruses have evolved to manipulate immune responses. Having previously been Head of the School of Biosciences and Medicine for 8 years.[1] He is also a co-founder of Ducentis BioTherapeutics to produce a novel anti-inflammatory therapeutic drug and until September 2022, was non-executive board member. Blackbourn is an Editor-in-Chief of FEMS Microbiology Reviews.[2]
- ^ "Celebrating students' achievement in biosciences | University of Surrey". University of Surrey. Retrieved 2022-05-13.
- ^ "Meet the new Editors-in-Chief of FEMS Microbiology Reviews: David J. Blackbourn (1 of 3)". FEMS. 13 May 2019.